Citadel Advisors’s Baird Medical Investment Holdings BDMD Stock Holding History

Citadel Advisors’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-112,660	Closed	-$153K	–	14548
2025 Q4	$153K	Buy	112,660 +66,128	+142%	+$96.2K	﹤0.01%	11293
2025 Q3	$98.6K	Buy	+46,532	New	+$119K	﹤0.01%	11858

Other funds holding BDMD

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Citadel Advisors's BDMD Position: Q1 2026 in Review

Citadel Advisors sold out of Baird Medical Investment Holdings (BDMD) in Q1 2026, closing a stake of 112,660 shares — an estimated $153K sold.

Citadel Advisors first reported a position in BDMD in Q3 2025 and held it in 2 quarters. The position peaked at $153K in Q4 2025. 8 funds tracked by Wall St. Rank hold BDMD as of Q1 2026.

Citadel Advisors reported no remaining Baird Medical Investment Holdings position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 112,660 Baird Medical Investment Holdings shares in Q1 2026, an estimated $153K.
Citadel Advisors first reported a position in Baird Medical Investment Holdings in Q3 2025 and held it in 2 quarters.
Citadel Advisors's Baird Medical Investment Holdings position peaked at $153K in Q4 2025.
8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.